|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities: | |||||
| Goodwill impairment | |||||
| Gain on bargain purchase | |||||
| Depreciation and amortization, net of accretion | |||||
| (Increase) decrease in cash surrender value of BOLI | |||||
| Gain on sale of capital assets | |||||
| Net investment (gains) losses | |||||
| Share-based compensation | |||||
| Deferred income tax expense (benefit) | |||||
| Policy acquisition costs, net of amortization (net deferral) | |||||
| Equity in (earnings) loss of unconsolidated subsidiaries | |||||
| Distributed earnings from unconsolidated subsidiaries | |||||
| Other, net | |||||
| Change in: | |||||
| Premiums receivable | |||||
| Reinsurance related assets and liabilities | |||||
| Other assets | |||||
| Reserve for losses and loss adjustment expenses | |||||
| Unearned premiums | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Purchases of: | |||||
| Fixed maturities, available-for-sale | |||||
| Equity investments | |||||
| Other investments | |||||
| Investment in unconsolidated subsidiaries | |||||
| Proceeds from sales or maturities of: | |||||
| Fixed maturities, available-for-sale | |||||
| Equity investments | |||||
| Other investments | |||||
| Net sales or (purchases) of fixed maturities, trading | |||||
| Return of invested capital from unconsolidated subsidiaries | |||||
| Net sales or maturities (purchases) of short-term investments | |||||
| Unsettled security transactions, net change | |||||
| Purchases of capital assets | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Proceeds from sale of capital assets | |||||
| Net cash impact of deconsolidation of closed years of account from Lloyd's Syndicates operations | |||||
| Other | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities | |||||
| Borrowings (repayments) under Revolving Credit Agreement | |||||
| Repayments of Senior Notes | |||||
| Repayments of Mortgage Loans | |||||
| Repurchase of common stock | |||||
| Dividends to shareholders | |||||
| Capital contribution received from (return of capital to) external segregated portfolio cell participants | |||||
| Purchase of non-controlling interest | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental Disclosure of Cash Flow Information | |||||
| Cash paid (refunded) during the year for income taxes, net | |||||
| Cash paid during the year for interest | |||||
| Significant Non-Cash Transactions | |||||
| Operating lease liabilities arising from obtaining ROU assets | |||||
| Dividends declared and not yet paid | |||||
| Fair value of Contribution Certificates issued in NORCAL acquisition | |||||
| Fair value of contingent consideration in NORCAL acquisition | |||||
| Increase (decrease) in fair value of contingent consideration issued in NORCAL acquisition | |||||
Loading...